Thursday - May 22, 2025
UC-San Francisco: Diabetes Medication May Increase Risk of Perioperative Ketoacidosis
May 01, 2025
SAN FRANCISCO, California, May 1 -- The University of California San Francisco campus issued the following news release:

* * *

Diabetes Medication May Increase Risk of Perioperative Ketoacidosis

UCSF study finds sodium-glucose cotransporter-2 inhibitors also lower risk of post-operative acute kidney injury.

By Melinda Krigel

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products